Healthtech Series B Investors & VC Firms
1216 firms in this list, with a median first check of $750K. 285 of them lead rounds. Generated from verified public data and updated continuously.
PBM Capital
CharlottesvilleSeed–Late Stage
6 people
SBCVC
TortolaSeed–Late Stage
6 people
Globalive Capital
TorontoPre-Seed–Growth
8 people
HBM Partners
ZugPre-Seed–Late Stage$5M – $50M
5 people
Health2047 Capital Partners LLC
Menlo ParkSeed–Late Stage
5 people
JJDC
New BrunswickSeed–Series B$500K – $5M
11 people
Mubadala Capital
LondonSeries A–Late Stage$1M – $50M
5 people
NewMargin Ventures
ShanghaiPre-Seed–Late Stage$425K – $200M
5 people
Sectoral Asset Management
MontrealSeries A–Late Stage
8 people
Verdane
StockholmSeries B–Growth$21.6M – $162M
11 people
TRICAPITAL
Scottish BordersSeed–Growth$315K – $2.5M
2 people
Urania Ventures
BerlinSeed–Late Stage
2 people
Split Rock Partners
Eden PrairieSeed–Late Stage$2M – $40M
4 people
Happiness Capital
Hong KongSeed–Growth
6 people
4see Ventures
Chêne-BougeriesPre-Seed–Series B$432K – $1.1M
2 people
MIRAIDOOR Co. Ltd.
KyotoPre-Seed–Growth$933K – $58M
1 person
Dementia Discovery
LondonPre-Seed–Series C
6 people
GTR Ventures
Seed–Series C$500K – $15M
3 people
Medical Incubator Japan K.K.
TokyoSeries A–Series B
Mithera Capital
SeattleSeed–Late Stage
6 people
SPRINT Accelerator
MoscowPre-Seed–Growth
Sumisho Venture Partners
TokyoSeed–Growth
5 people
Fujitsu Ventures
TokyoSeed–Growth
Development Bank of Wales
CardiffPre-Seed–Late Stage$12.7K – $12.7M
10 people
Related lists
Series B Investors & VC Firms (4094)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Series B Investors & VC Firms in United States (1625)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)
Data sourced from public filings and firms' own websites — see our methodology.

































